Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).
Sant P. Chawla
Consultant or Advisory Role - CytRx Corporation; Merck; PharmaMar; Roche/Genentech; Sanofi
Research Funding - CytRx Corporation; Merck; PharmaMar; Sanofi
Jean-Yves Blay
Consultant or Advisory Role - GlaxoSmithKline; MSD; Novartis; Pfizer; PharmaMar; Roche
Honoraria - GlaxoSmithKline; MSD; Novartis; Pfizer; PharmaMar; Roche
Research Funding - GlaxoSmithKline; MSD; Novartis; Pfizer; PharmaMar; Roche
Expert Testimony - MSD (U)
Antoine Italiano
Research Funding - GlaxoSmithKline; Novartis; Pfizer; PharmaMar (B); Roche
Martin Gutierrez
No relevant relationships to disclose
Axel Le Cesne
Honoraria - Novartis; Pfizer; PharmaMar
Carlos Alberto Gomez-Roca
No relevant relationships to disclose
Launce G. Gouw
No relevant relationships to disclose
Margaret von Mehren
No relevant relationships to disclose
Andrew Wagner
Consultant or Advisory Role - Roche; Sanofi
Research Funding - Merck; Novartis; Pfizer; Roche/Genentech
Robert G. Maki
Consultant or Advisory Role - Roche
Research Funding - Roche
Brian Higgins
Employment or Leadership Position - Roche
Stock Ownership - Roche
Steven Middleton
Employment or Leadership Position - Roche
Stock Ownership - Roche
Gwen L. Nichols
Employment or Leadership Position - Roche
Stock Ownership - Roche
David Geho
Employment or Leadership Position - Roche
Stock Ownership - Roche
Steven Blotner
Employment or Leadership Position - Roche
Stock Ownership - Roche
Jianguo Zhi
Employment or Leadership Position - Roche
Stock Ownership - Roche
Lin Chi Chen
Employment or Leadership Position - Roche
Stock Ownership - Roche